CRYOSUPERNATANT PLASMA FRACTION IN COMPLEX TREATMENT OF WIDESPREAD SOFT TISSUE PHLEGMON
УДК 616-002.36:616.94:615.382
DOI:
https://doi.org/10.31684/25418475-2024-1-29Keywords:
cryoplasma-antiferment complex, freshly frozen plasma, cryosupernatant plasma, sepsis, disseminated intravascular coagulation syndrome, phlegmonAbstract
The study aimed to compare the outcomes of treating patients with widespread soft tissue phlegmon complicated by sepsis using cryosupernatant plasma and freshly frozen plasma. A total of 61 sepsis-diagnosed patients were involved in the study, divided into two groups. Group 1 received complex treatment with cryosupernatant plasma (CSNP), while group 2 received fresh frozen plasma (FFP). The use of CSNP in the complex treatment of septic patients, as opposed to FFP, resulted in improved treatment outcomes, reduced progression of multiple organ failure, prevention of thrombotic and thromboembolic complications, decreased mortality, and faster normalization of hemocoagulation and fibrinolysis system indicators.
Downloads
Download data is not yet available.
References
Downloads
Published
2024-03-25
How to Cite
Tseimakh E. A., Zinchenko V. Y., Lavrinenko O. Y., Kalashnikov A. V., Shalabod E. A. CRYOSUPERNATANT PLASMA FRACTION IN COMPLEX TREATMENT OF WIDESPREAD SOFT TISSUE PHLEGMON: УДК 616-002.36:616.94:615.382 // Bulletin of Medical Science, 2024. Vol. 33, № 1. P. 29–38 DOI: 10.31684/25418475-2024-1-29. URL: https://newbmn.asmu.ru/bmn/article/view/661.
Issue
Section
ORIGINAL PAPERS